{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:01Z","timestamp":1793256181038,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T00:00:00Z","timestamp":1256601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/nrneph.2009.184","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T09:23:53Z","timestamp":1256635433000},"page":"713-721","source":"Crossref","is-referenced-by-count":303,"title":["An update on the lipid nephrotoxicity hypothesis"],"prefix":"10.1038","volume":"5","author":[{"given":"Xiong Z.","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zac","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Moorhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,27]]},"reference":[{"key":"BFnrneph2009184_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead, J. F., Chan, M. K., El-Nahas, M. & Varghese, Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2, 1309\u20131311 (1982).","journal-title":"Lancet"},{"key":"BFnrneph2009184_CR2","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","volume":"43","author":"KK Berneis","year":"2002","unstructured":"Berneis, K. K. & Krauss, R. M. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 43, 1363\u20131379 (2002).","journal-title":"J. Lipid Res."},{"key":"BFnrneph2009184_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.291.4.451","volume":"291","author":"Y Liu","year":"2004","unstructured":"Liu, Y. et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291, 451\u2013459 (2004).","journal-title":"JAMA"},{"key":"BFnrneph2009184_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","volume":"15","author":"EG Lowrie","year":"1990","unstructured":"Lowrie, E. G. & Lew, N. L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am. J. Kidney Dis. 15, 458\u2013482 (1990).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009184_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trsl.2008.11.007","volume":"153","author":"H Moradi","year":"2009","unstructured":"Moradi, H., Pahl, M. V., Elahimehr, R. & Vaziri, N. D. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease. Transl. Res. 153, 77\u201385 (2009).","journal-title":"Transl. Res."},{"key":"BFnrneph2009184_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ki.2009.177","volume":"76","author":"ND Vaziri","year":"2009","unstructured":"Vaziri, N. D., Moradi, H., Pahl, M. V., Fogelman, A. M. & Navab, M. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int. 76, 437\u2013444 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR7","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/ki.2008.520","volume":"74","author":"C Wanner","year":"2008","unstructured":"Wanner, C. & Ritz, E. Reducing lipids for CV protection in CKD patients\u2014current evidence. Kidney Int. Suppl. 74, S24\u2013S28 (2008).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2009184_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ki.1981.62","volume":"19","author":"MK Chan","year":"1981","unstructured":"Chan, M. K., Varghese, Z. & Moorhead, J. F. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int. 19, 625\u2013637 (1981).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR9","first-page":"204","volume":"83","author":"SW French","year":"1967","unstructured":"French, S. W., Yamanaka, W. & Ostwald, R. Dietary induced glomerulosclerosis in the guinea pig. Arch. Pathol. 83, 204\u2013210 (1967).","journal-title":"Arch. Pathol."},{"key":"BFnrneph2009184_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0021-9150(83)90164-8","volume":"46","author":"L Peric-Golia","year":"1983","unstructured":"Peric-Golia, L. & Peric-Golia, M. Aortic and renal lesions in hypercholesterolemic adult, male, virgin Sprague-Dawley rats. Atherosclerosis 46, 57\u201365 (1983).","journal-title":"Atherosclerosis"},{"key":"BFnrneph2009184_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ki.1990.62","volume":"37","author":"BL Kasiske","year":"1990","unstructured":"Kasiske, B. L., O'Donnell, M. P., Schmitz, P. G., Kim, Y. & Keane, W. F. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int. 37, 880\u2013891 (1990).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR12","first-page":"433","volume":"60","author":"HJ Gr\u00f6ne","year":"1989","unstructured":"Gr\u00f6ne, H. J. et al. Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. Lab. Invest. 60, 433\u2013446 (1989).","journal-title":"Lab. Invest."},{"key":"BFnrneph2009184_CR13","doi-asserted-by":"publisher","first-page":"F1297","DOI":"10.1152\/ajprenal.90761.2008","volume":"296","author":"HJ Kim","year":"2009","unstructured":"Kim, H. J., Moradi, H., Yuan, J., Norris, K. & Vaziri, N. D. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 296, F1297\u2013F1306 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2009184_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ki.1997.158","volume":"51","author":"HS Lee","year":"1997","unstructured":"Lee, H. S. et al. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int. 51, 1151\u20131159 (1997).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR15","first-page":"1804","volume":"142","author":"H van Goor","year":"1993","unstructured":"van Goor, H. et al. Renal apolipoproteins in nephrotic rats. Am. J. Pathol. 142, 1804\u20131812 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2009184_CR16","first-page":"598","volume":"106","author":"BL Kasiske","year":"1985","unstructured":"Kasiske, B. L., Cleary, M. P., O'Donnell, M. P. & Keane, W. F. Effects of genetic obesity on renal structure and function in the Zucker rat. J. Lab. Clin. Med. 106, 598\u2013604 (1985).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph2009184_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0021-9150(77)90054-5","volume":"27","author":"Y Imai","year":"1977","unstructured":"Imai, Y., Matsumura, H., Miyajima, H. & Oka, K. Serum and tissue lipids and glomerulonephritis in the spontaneously hypercholesterolemic (SHC) rat, with a note on the effects of gonadectomy. Atherosclerosis 27, 165\u2013178 (1977).","journal-title":"Atherosclerosis"},{"key":"BFnrneph2009184_CR18","first-page":"129","volume":"80","author":"S Koletsky","year":"1975","unstructured":"Koletsky, S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am. J. Pathol. 80, 129\u2013142 (1975).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2009184_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/BF00190332","volume":"71","author":"HJ Gr\u00f6ne","year":"1993","unstructured":"Gr\u00f6ne, H. J., Walli, A. K. & Grone, E. F. Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis. Clin. Investig. 71, 834\u2013839 (1993).","journal-title":"Clin. Investig."},{"key":"BFnrneph2009184_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ndt\/18.1.27","volume":"18","author":"XZ Ruan","year":"2003","unstructured":"Ruan, X. Z., Varghese, Z. & Moorhead, J. F. Inflammation modifies lipid-mediated renal injury. Nephrol. Dial. Transplant. 18, 27\u201332 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl. 1","key":"BFnrneph2009184_CR21","first-page":"38","volume":"17","author":"WF Keane","year":"1991","unstructured":"Keane, W. F., Kasiske, B. L., O'Donnell, M. P. & Kim, Y. The role of altered lipid metabolism in the progression of renal disease: experimental evidence. Am. J. Kidney Dis. 17 (Suppl. 1), 38\u201342 (1991).","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl. 1","key":"BFnrneph2009184_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01800570","volume":"11","author":"N McIntyre","year":"1988","unstructured":"McIntyre, N. Familial LCAT deficiency and fish-eye disease. J. Inherit. Metab. Dis. 11 (Suppl. 1), 45\u201356 (1988).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnrneph2009184_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0272-6386(12)80539-7","volume":"20","author":"RE Tracy","year":"1992","unstructured":"Tracy, R. E. Blood pressure related separately to parenchymal fibrosis and vasculopathy of the kidney. Am. J. Kidney Dis. 20, 124\u2013131 (1992).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009184_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/08860229309054950","volume":"15","author":"JF Moorhead","year":"1993","unstructured":"Moorhead, J. F., Persaud, W., Varghese, Z. & Sweny, P. Serum cholesterol falls spontaneously in nephrotic patients with progressive renal disease. Ren. Fail. 15, 389\u2013393 (1993).","journal-title":"Ren. Fail."},{"key":"BFnrneph2009184_CR25","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1681\/ASN.V1482084","volume":"14","author":"ES Schaeffner","year":"2003","unstructured":"Schaeffner, E. S. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J. Am. Soc. Nephrol. 14, 2084\u20132091 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ahj.2005.03.055","volume":"151","author":"BC Astor","year":"2006","unstructured":"Astor, B. C., Coresh, J., Heiss, G., Pettitt, D. & Sarnak, M. J. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 151, 492\u2013500 (2006).","journal-title":"Am. Heart J."},{"key":"BFnrneph2009184_CR27","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V981482","volume":"9","author":"O Samuelsson","year":"1998","unstructured":"Samuelsson, O. et al. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J. Am. Soc. Nephrol. 9, 1482\u20131488 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MAJ.0b013e3181a92804","volume":"338","author":"PH Lee","year":"2009","unstructured":"Lee, P. H. et al. Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. Am. J. Med. Sci. 338, 185\u2013189 (2009).","journal-title":"Am. J. Med. Sci."},{"key":"BFnrneph2009184_CR29","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1046\/j.1523-1755.2002.00626.x","volume":"62","author":"M Tozawa","year":"2002","unstructured":"Tozawa, M. et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 62, 1743\u20131749 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra011295","volume":"346","author":"M Pascual","year":"2002","unstructured":"Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N. & Cosimi, A. B. Strategies to improve long-term outcomes after renal transplantation. N. Engl. J. Med. 346, 580\u2013590 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009184_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","volume":"63","author":"JA Kobashigawa","year":"1997","unstructured":"Kobashigawa, J. A. & Kasiske, B. L. Hyperlipidemia in solid organ transplantation. Transplantation 63, 331\u2013338 (1997).","journal-title":"Transplantation"},{"key":"BFnrneph2009184_CR32","first-page":"67","volume":"36","author":"HS Lee","year":"1991","unstructured":"Lee, H. S., Lee, J. S., Koh, H. I. & Ko, K. W. Intraglomerular lipid deposition in routine biopsies. Clin. Nephrol. 36, 67\u201375 (1991).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2009184_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/BF00858822","volume":"4","author":"Y Koitabashi","year":"1990","unstructured":"Koitabashi, Y. et al. Long-term follow-up of a paediatric case of lipoprotein glomerulopathy. Pediatr. Nephrol. 4, 122\u2013128 (1990).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2009184_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/ki.1993.129","volume":"43","author":"T Takemura","year":"1993","unstructured":"Takemura, T. et al. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int. 43, 918\u2013927 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR35","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.clinbiochem.2009.05.010","volume":"42","author":"EM Vasconcelos","year":"2009","unstructured":"Vasconcelos, E. M. et al. Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin. Biochem. 42, 1222\u20131227 (2009).","journal-title":"Clin. Biochem."},{"key":"BFnrneph2009184_CR36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/0002-8703(93)90102-F","volume":"125","author":"K Prasad","year":"1993","unstructured":"Prasad, K. & Kalra, J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am. Heart J. 125, 958\u2013973 (1993).","journal-title":"Am. Heart J."},{"key":"BFnrneph2009184_CR37","first-page":"1","volume":"2","author":"ND Vaziri","year":"2008","unstructured":"Vaziri, N. D. Causal link between oxidative stress, inflammation, and hypertension. Iran J. Kidney Dis. 2, 1\u201310 (2008).","journal-title":"Iran J. Kidney Dis."},{"key":"BFnrneph2009184_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ki.1992.262","volume":"42","author":"GP Oberle","year":"1992","unstructured":"Oberle, G. P., Niemeyer, J., Thaiss, F., Schoeppe, W. & Stahl, R. A. Increased oxygen radical and eicosanoid formation in immune-mediated mesangial cell injury. Kidney Int. 42, 69\u201374 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/MNH.0b013e32832923c3","volume":"18","author":"M Sedeek","year":"2009","unstructured":"Sedeek, M., H\u00e9bert, R. L., Kennedy, C. R., Burns, K. D. & Touyz, R. M. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr. Opin. Nephrol. Hypertens. 18, 122\u2013127 (2009).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2009184_CR40","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.ASN.0000111744.00916.E6","volume":"15","author":"GA Kaysen","year":"2004","unstructured":"Kaysen, G. A. & Eiserich, J. P. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J. Am. Soc. Nephrol. 15, 538\u2013548 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1358\/dot.2009.45.5.1377598","volume":"45","author":"I Suzuki","year":"2009","unstructured":"Suzuki, I., Yamauchi, T., Onuma, M. & Nozaki, S. Allopurinol, an inhibitor of uric acid synthesis\u2014can it be used for the treatment of metabolic syndrome and related disorders? Drugs Today (Barc.) 45, 363\u2013368 (2009).","journal-title":"Drugs Today (Barc.)"},{"issue":"Suppl. 2","key":"BFnrneph2009184_CR42","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.jhh.1001392","volume":"16","author":"I Gavras","year":"2002","unstructured":"Gavras, I. & Gavras, H. Angiotensin II as a cardiovascular risk factor. J. Hum. Hypertens. 16 (Suppl. 2), S2\u2013S6 (2002).","journal-title":"J. Hum. Hypertens."},{"key":"BFnrneph2009184_CR43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1046\/j.1523-1755.1999.00587.x","volume":"56","author":"XZ Ruan","year":"1999","unstructured":"Ruan, X. Z., Varghese, Z., Powis, S. H. & Moorhead, J. F. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int. 56, 440\u2013451 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR44","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1681\/ASN.2004080629","volume":"16","author":"B Bussolati","year":"2005","unstructured":"Bussolati, B. et al. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase\/AKT-signaling pathway. J. Am. Soc. Nephrol. 16, 1936\u20131947 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ndt\/8.6.512","volume":"8","author":"RL Fernando","year":"1993","unstructured":"Fernando, R. L., Varghese, Z. & Moorhead, J. F. Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro. Nephrol. Dial. Transplant. 8, 512\u2013518 (1993).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2009184_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1172\/JCI112371","volume":"77","author":"JW Heinecke","year":"1986","unstructured":"Heinecke, J. W., Baker, L., Rosen, H. & Chait, A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77, 757\u2013761 (1986).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2009184_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0009-3084(92)90057-V","volume":"62","author":"B Malavasi","year":"1992","unstructured":"Malavasi, B. et al. Evidence for the presence of 7-hydroperoxycholest-5-en-3 beta-ol in oxidized human LDL. Chem. Phys. Lipids 62, 209\u2013214 (1992).","journal-title":"Chem. Phys. Lipids"},{"key":"BFnrneph2009184_CR48","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1172\/JCI118576","volume":"97","author":"LJ Hazell","year":"1996","unstructured":"Hazell, L. J. et al. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535\u20131544 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2009184_CR49","first-page":"98","volume":"51","author":"MM Rahman","year":"1999","unstructured":"Rahman, M. M., Varghese, Z., Fuller, B. J. & Moorhead, J. F. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine. Clin. Nephrol. 51, 98\u2013107 (1999).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2009184_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/j.ackd.2006.07.010","volume":"13","author":"L Chalmers","year":"2006","unstructured":"Chalmers, L., Kaskel, F. J. & Bamgbola, O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv. Chronic Kidney Dis. 13, 352\u2013364 (2006).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph2009184_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0168-8227(99)00040-6","volume":"45","author":"HS Lee","year":"1999","unstructured":"Lee, H. S. Oxidized LDL, glomerular mesangial cells and collagen. Diabetes Res. Clin. Pract. 45, 117\u2013122 (1999).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrneph2009184_CR52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519\u2013529 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneph2009184_CR53","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI0216452","volume":"110","author":"I Tabas","year":"2002","unstructured":"Tabas, I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest 110, 905\u2013911 (2002).","journal-title":"J. Clin. Invest"},{"key":"BFnrneph2009184_CR54","doi-asserted-by":"publisher","first-page":"e4954","DOI":"10.1371\/journal.pone.0004954","volume":"4","author":"E Bachar","year":"2009","unstructured":"Bachar, E. et al. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1. PLoS One 4, e4954 (2009).","journal-title":"PLoS One"},{"key":"BFnrneph2009184_CR55","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1074\/jbc.M809064200","volume":"284","author":"WJ Kovacs","year":"2009","unstructured":"Kovacs, W. J. et al. Peroxisome deficiency causes a complex phenotype because of hepatic SREBP\/Insig dysregulation associated with endoplasmic reticulum stress. J. Biol. Chem. 284, 7232\u20137245 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2009184_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","volume":"59","author":"C Guijarro","year":"2001","unstructured":"Guijarro, C. & Egido, J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int. 59, 415\u2013424 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR57","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1046\/j.1523-1755.1999.07113.x","volume":"71","author":"Y Nishida","year":"1999","unstructured":"Nishida, Y., Oda, H. & Yorioka, N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. Suppl. 71, S51\u2013S53 (1999).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2009184_CR58","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/01.ATV.18.9.1450","volume":"18","author":"DT Ashby","year":"1998","unstructured":"Ashby, D. T. et al. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18, 1450\u20131455 (1998).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2009184_CR59","doi-asserted-by":"publisher","first-page":"F679","DOI":"10.1152\/ajprenal.90680.2008","volume":"297","author":"M Tomiyama-Hanayama","year":"2009","unstructured":"Tomiyama-Hanayama, M. et al. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice. Am. J. Physiol. Renal Physiol. 297, F679\u2013F784 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2009184_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000082013","volume":"23","author":"SM Moe","year":"2005","unstructured":"Moe, S. M. & Chen, N. X. Inflammation and vascular calcification. Blood Purif. 23, 64\u201371 (2005).","journal-title":"Blood Purif."},{"key":"BFnrneph2009184_CR61","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1053\/j.ackd.2008.07.011","volume":"15","author":"Z Al-Aly","year":"2008","unstructured":"Al-Aly, Z. Vascular calcification in uremia: what is new and where are we going? Adv. Chronic Kidney Dis. 15, 413\u2013419 (2008).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph2009184_CR62","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/ki.1991.108","volume":"39","author":"G Coritsidis","year":"1991","unstructured":"Coritsidis, G. et al. Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int. 39, 858\u2013866 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR63","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1172\/JCI114562","volume":"85","author":"JA Berliner","year":"1990","unstructured":"Berliner, J. A. et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85, 1260\u20131266 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2009184_CR64","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1111\/j.1523-1755.2005.09916.x","volume":"68","author":"A Cases","year":"2005","unstructured":"Cases, A. & Coll, E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int. Suppl. 68, S87\u2013S93 (2005).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2009184_CR65","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1073\/pnas.84.9.2995","volume":"84","author":"MT Quinn","year":"1987","unstructured":"Quinn, M. T., Parthasarathy, S., Fong, L. G. & Steinberg, D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte\/macrophages during atherogenesis. Proc. Natl Acad. Sci. USA 84, 2995\u20132998 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2009184_CR66","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","volume":"91","author":"JA Berliner","year":"1995","unstructured":"Berliner, J. A. et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91, 2488\u20132496 (1995).","journal-title":"Circulation"},{"key":"BFnrneph2009184_CR67","first-page":"F937","volume":"267","author":"G Ding","year":"1994","unstructured":"Ding, G., van Goor, H., Frye, J. & Diamond, J. R. Transforming growth factor-beta expression in macrophages during hypercholesterolemic states. Am. J. Physiol. 267, F937\u2013F943 (1994).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2009184_CR68","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/j.ajkd.2003.10.037","volume":"43","author":"MJ Landray","year":"2004","unstructured":"Landray, M. J. et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am. J. Kidney Dis. 43, 244\u2013253 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009184_CR69","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/01.CIR.102.8.833","volume":"102","author":"M Mayr","year":"2002","unstructured":"Mayr, M., Kiechl, S., Willeit, J., Wick, G. & Xu, Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102, 833\u2013839 (2002).","journal-title":"Circulation"},{"key":"BFnrneph2009184_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/01.CIR.103.1.108","volume":"103","author":"GW Cockerill","year":"2001","unstructured":"Cockerill, G. W. et al. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 103, 108\u2013112 (2001).","journal-title":"Circulation"},{"key":"BFnrneph2009184_CR71","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker, P. M., Hennekens, C. H., Buring, J. E. & Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342, 836\u2013843 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009184_CR72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.ATV.14.1.8","volume":"14","author":"WH Ettinger","year":"1994","unstructured":"Ettinger, W. H. et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler. Thromb. 14, 8\u201313 (1994).","journal-title":"Arterioscler. Thromb."},{"key":"BFnrneph2009184_CR73","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.metabol.2004.05.001","volume":"53","author":"MC Batista","year":"2004","unstructured":"Batista, M. C. et al. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism 53, 1255\u20131261 (2004).","journal-title":"Metabolism"},{"key":"BFnrneph2009184_CR74","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1046\/j.1523-1755.2001.00025.x","volume":"60","author":"XZ Ruan","year":"2001","unstructured":"Ruan, X. Z., Varghese, Z., Powis, S. H. & Moorhead, J. F. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int. 60, 1716\u20131725 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR75","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1161\/01.ATV.0000217957.93135.c2","volume":"26","author":"XZ Ruan","year":"2006","unstructured":"Ruan, X. Z. et al. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler. Thromb. Vasc. Biol. 26, 1150\u20131155 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2009184_CR76","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.ASN.0000050414.52908.DA","volume":"14","author":"XZ Ruan","year":"2003","unstructured":"Ruan, X. Z. et al. PPAR agonists protect mesangial cells from Interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J. Am. Soc. Nephrol. 14, 593\u2013600 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR77","doi-asserted-by":"publisher","first-page":"F680","DOI":"10.1152\/ajprenal.00209.2007","volume":"293","author":"Y Chen","year":"2007","unstructured":"Chen, Y. et al. Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells. Am. J. Physiol. Renal Physiol. 293, F680\u2013F687 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2009184_CR78","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.22423","volume":"48","author":"KL Ma","year":"2008","unstructured":"Ma, K. L. et al. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology 48, 770\u2013781 (2008).","journal-title":"Hepatology"},{"key":"BFnrneph2009184_CR79","first-page":"TH-FC013","volume":"19","author":"XZ Ruan","year":"2008","unstructured":"Ruan, X. Z. et al. Inflammation may cause a paradoxical association between serum cholesterol and cardiovascular events by diverting lipid from plasma to tissue compartments [abstract]. J. Am. Soc. Nephrol. 19, TH-FC013 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR80","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000210020","volume":"30","author":"H Moradi","year":"2009","unstructured":"Moradi, H., Yuan, J., Ni, Z., Norris, K. & Vaziri, N. D. Reverse cholesterol transport pathway in experimental chronic renal failure. Am. J. Nephrol. 30, 147\u2013154 (2009).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2009184_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ki.2008.195","volume":"74","author":"HL Zhao","year":"2008","unstructured":"Zhao, H. L. et al. Fat redistribution and adipocyte transformation in uninephrectomized rats. Kidney Int. 74, 467\u2013477 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200502078","volume":"171","author":"T Devries-Seimon","year":"2005","unstructured":"Devries-Seimon, T. et al. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell Biol. 171, 61\u201373 (2005).","journal-title":"J. Cell Biol."},{"key":"BFnrneph2009184_CR83","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2125.2003.02060.x","volume":"57","author":"BM Cheung","year":"2004","unstructured":"Cheung, B. M., Lauder, I. J., Lau, C. P. & Kumana, C. R. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br. J. Clin. Pharmacol. 57, 640\u2013651 (2004).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BFnrneph2009184_CR84","unstructured":"K\/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am. J. Kidney Dis. 41 (Suppl. 3), S1\u2013S92 (2003)."},{"key":"BFnrneph2009184_CR85","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.ASN.0000068461.45784.2F","volume":"14","author":"M Tonelli","year":"2003","unstructured":"Tonelli, M., Moye, L., Sacks, F. M., Cole, T. & Curhan, G. C. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J. Am. Soc. Nephrol. 14, 1605\u20131613 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR86","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/jcp.2003.012989","volume":"57","author":"VG Athyros","year":"2004","unstructured":"Athyros, V. G. et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J. Clin. Pathol. 57, 728\u2013734 (2004).","journal-title":"J. Clin. Pathol."},{"key":"BFnrneph2009184_CR87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000077704","volume":"102","author":"DG Vidt","year":"2004","unstructured":"Vidt, D. G., Cressman, M. D., Harris, S., Pears, J. S. & Hutchinson, H. G. Rosuvastatin-induced arrest in progression of renal disease. Cardiology 102, 52\u201360 (2004).","journal-title":"Cardiology"},{"key":"BFnrneph2009184_CR88","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1681\/ASN.2005070779","volume":"16","author":"M Tonelli","year":"2005","unstructured":"Tonelli, M. et al. Effect of pravastatin in people with diabetes and chronic kidney disease. J. Am. Soc. Nephrol. 16, 3748\u20133754 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR89","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","volume":"59","author":"LF Fried","year":"2001","unstructured":"Fried, L. F., Orchard, T. J. & Kasiske, B. L. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 59, 260\u2013269 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2009184_CR90","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1681\/ASN.2006010012","volume":"17","author":"S Sandhu","year":"2006","unstructured":"Sandhu, S., Wiebe, N., Fried, L. F. & Tonelli, M. Statins for improving renal outcomes: a meta-analysis. J. Am. Soc. Nephrol. 17, 2006\u20132016 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR91","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","volume":"41","author":"S Bianchi","year":"2003","unstructured":"Bianchi, S., Bigazzi, R., Caiazza, A. & Campese, V. M. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am. J. Kidney Dis. 41, 565\u2013570 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009184_CR92","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.HYP.0000022805.11288.7F","volume":"40","author":"TM Lee","year":"2002","unstructured":"Lee, T. M., Su, S. F. & Tsai, C. H. Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension 40, 67\u201373 (2002).","journal-title":"Hypertension"},{"key":"BFnrneph2009184_CR93","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1185\/03007990802622064","volume":"25","author":"B Fellstr\u00f6m","year":"2009","unstructured":"Fellstr\u00f6m, B. et al. Cardiovascular disease in patients with renal disease: the role of statins. Curr. Med. Res. Opin. 25, 271\u2013285 (2009).","journal-title":"Curr. Med. Res. Opin."},{"key":"BFnrneph2009184_CR94","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1042\/bj3080991","volume":"308","author":"S Dusi","year":"1995","unstructured":"Dusi, S., Donini, M. & Rossi, F. Mechanisms of NADPH oxidase activation in human neutrophils: p67phox is required for the translocation of rac 1 but not of rac 2 from cytosol to the membranes. Biochem. J. 308, 991\u2013994 (1995).","journal-title":"Biochem. J."},{"key":"BFnrneph2009184_CR95","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1210\/en.2006-1355","volume":"148","author":"J Habibi","year":"2007","unstructured":"Habibi, J. et al. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology 148, 2181\u20132188 (2007).","journal-title":"Endocrinology"},{"key":"BFnrneph2009184_CR96","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/01.HYP.0000179088.57586.26","volume":"46","author":"VM Campese","year":"2005","unstructured":"Campese, V. M., Shaohua, Y. & Huiquin, Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46, 533\u2013539 (2005).","journal-title":"Hypertension"},{"key":"BFnrneph2009184_CR97","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","volume":"23","author":"S Wolfrum","year":"2003","unstructured":"Wolfrum, S., Jensen, K. S. & Liao, J. K. Endothelium-dependent effects of statins. Arterioscler. Thromb. Vasc. Biol. 23, 729\u2013736 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2009184_CR98","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1525-1594.2005.29097.x","volume":"29","author":"M Chmielewski","year":"2005","unstructured":"Chmielewski, M. et al. Expression of scavenger receptor CD36 in chronic renal failure patients. Artif. Organs 29, 608\u2013614 (2005).","journal-title":"Artif. Organs"},{"key":"BFnrneph2009184_CR99","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1210\/jcem.87.4.8412","volume":"87","author":"SI McFarlane","year":"2002","unstructured":"McFarlane, S. I., Muniyappa, R., Francisco, R. & Sowers, J. R. Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J. Clin. Endocrinol. Metab. 87, 1451\u20131458 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2009184_CR100","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1006\/bbrc.1999.1992","volume":"267","author":"ZA Massy","year":"2000","unstructured":"Massy, Z. A. et al. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin. Biochem. Biophys. Res. Commun. 267, 536\u2013540 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2009184_CR101","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/phrs.2001.0922","volume":"45","author":"I Zelvyte","year":"2002","unstructured":"Zelvyte, I., Dominaitiene, R., Crisby, M. & Janciauskiene, S. Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol. Res. 45, 147\u2013154 (2002).","journal-title":"Pharmacol. Res."},{"key":"BFnrneph2009184_CR102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2261-3-6","volume":"3","author":"JE Vamvakopoulos","year":"2003","unstructured":"Vamvakopoulos, J. E. & Green, C. HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection. BMC Cardiovasc. Disord. 3, 6 (2003).","journal-title":"BMC Cardiovasc. Disord."},{"key":"BFnrneph2009184_CR103","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.04371206","volume":"2","author":"J Shepherd","year":"2007","unstructured":"Shepherd, J. et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin. J. Am. Soc. Nephrol. 2, 1131\u20131139 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009184_CR104","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238\u2013248 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009184_CR105","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","volume":"360","author":"BC Fellstr\u00f6m","year":"2009","unstructured":"Fellstr\u00f6m, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395\u20131407 (2009).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.184","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:54:26Z","timestamp":1739400866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2009.184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,27]]},"references-count":105,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["BFnrneph2009184"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2009.184","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,27]]}}}